Testing effectiveness (Phase 2)Looking for participantsNCT07092865
What this trial is testing
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 184